Weave Communications, Inc.
NYSE:WEAVSoftware - Application
-$0.09 today
- Market cap
- $595.33M
- Beta
- 1.69
- P/E (TTM)
- -16.4
- EPS (TTM)
- -$0.32
Volume 1.24M
Average 1.30M
WEAV Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Weave Communications, Inc.NYSE: WEAV
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development dips below year-ago levels
Q1 FY2026 research & development of $10.81M fell 3.0% year over year, behind the +5.7% change in trailing-twelve-month research & development. Sequentially, it rose 31.9% from the prior quarter. Over 3 fiscal years it compounded at +13.1% a year.
Context
- Research & development amounted to 18.6% of revenue in FY2025, down 1.1 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -3.0% toward the trailing-twelve-month pace of +5.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 44.46M USD
- Year-over-year change
- +10.5%
- 4-year CAGR
- +13.3%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 44.46M | +10.5% |
| FY2024 | 2024-12-31 | 40.23M | +18.2% |
| FY2023 | 2023-12-31 | 34.04M | +10.8% |
| FY2022 | 2022-12-31 | 30.71M | +13.7% |
| FY2021 | 2021-12-31 | 27.01M | — |
Research & Development vs competitors
How WEAV compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +5.7% is the 6th highest of 10, against a peer median of +7.9%.
- Research & development amounts to 17.7% of revenue for WEAV, versus a peer median of 30.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $110.37M USD | +14.6% | +5.3% | 11.9% | |
| LTM Mar 2026 | $108.55M USD | +7.9% | -3.0% | 35.9% | |
| LTM Mar 2026 | $105M USD | +2.7% | +18.1% | 22.4% | |
| LTM Apr 2026 | $75.88M USD | -10.9% | -6.7% | 23.8% | |
| LTM Mar 2026 | $52.5M USD | +14.1% | +6.6% | 68.2% | |
| LTM Mar 2026 | $45.54M USD | +3.0% | +11.7% | 30.4% | |
| LTM Mar 2026 | $44.12M USD | +5.7% | +13.1% | 17.7% | |
AMBQAmbiq Micro, Inc. | LTM Mar 2026 | $42.63M USD | +17.1% | — | 52.1% |
| LTM Mar 2026 | $28.96M USD | +16.8% | — | 71.8% | |
NBPNovaBridge Biosciences | LTM Sep 2025 | CN¥13.28M CNY | -94.8% | -61.3% | — |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding WEAV) | — | +7.9% | +5.3% | 30.4% | |
Competitors are the stored peer set for WEAV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 115.87M | 142.12M | 170.47M | 204.31M | 239.02M |
| Cost of Revenue | 49.37M | 53.28M | 54.38M | 58.43M | 66.72M |
| Gross Profit | 66.5M | 88.84M | 116.09M | 145.88M | 172.31M |
| Gross Margin | 57.4% | 62.5% | 68.1% | 71.4% | 72.1% |
| Research & Development | 27.01M | 30.71M | 34.04M | 40.23M | 44.46M |
| Selling, General & Admin | 89.88M | 107.83M | 116.42M | 137.06M | 158.46M |
| Operating Expenses | 116.89M | 138.55M | 150.46M | 177.3M | 200.89M |
| Depreciation & Amortization | 12.14M | 16.65M | 15.83M | 15.47M | 16.5M |
| EBITDA | (38.31M) | (31.55M) | (13.02M) | (11.17M) | (10.78M) |
| EBITDA Margin | -33.1% | -22.2% | -7.6% | -5.5% | -4.5% |
| Operating Income | (50.39M) | (49.7M) | (34.37M) | (31.41M) | (28.91M) |
| Operating Margin | -43.5% | -35.0% | -20.2% | -15.4% | -12.1% |
| Interest Income | 0 | 1.16M | 2.2M | 1.85M | 1.81M |
| Interest Expense | 1.18M | 1.44M | 1.92M | 1.52M | 1.7M |
| Other Income / Expenses | (1.24M) | 70K | 3.6M | 3.26M | (62K) |
| Income Before Tax | (51.63M) | (49.63M) | (30.77M) | (28.16M) | (28.98M) |
| Pre-Tax Margin | -44.6% | -34.9% | -18.1% | -13.8% | -12.1% |
| Income Tax Expense | 60K | 104K | 260K | 189K | (924K) |
| Net Income | (51.69M) | (49.74M) | (31.03M) | (28.35M) | (28.05M) |
| Net Margin | -44.6% | -35.0% | -18.2% | -13.9% | -11.7% |
| EPS (Basic) | (2.60) | (0.76) | (0.46) | (0.40) | (0.37) |
| EPS (Diluted) | (2.60) | (0.76) | (0.46) | (0.40) | (0.37) |
| Weighted Avg Shares | 64.32M | 65.74M | 67.69M | 71.66M | 76.31M |
| Weighted Avg Shares (Diluted) | 64.32M | 65.74M | 67.69M | 71.66M | 76.31M |
Weave Communications, Inc.
NYSE:WEAV
Intrinsic Alpha fair value
Locked
Current Price
$7.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.